SFDA Approves Registration of ‘Iqirvo’ for Treatment of Primary Biliary Cholangitis
Riyadh: The Saudi Food and Drug Authority (SFDA) has approved the registration of Iqirvo (Elafibranor) for the treatment of adults with primary biliary cholangitis (PBC) who have had an inadequate